Pancreatic Cancer Research

ResearcherUniversitätsklinikum AachenActive in the last 2 years

Yang Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0000-6802-8075; OpenAlex author ID A5101312458. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2025: 3 papers

Papers 3

  1. UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination. Co-author DOI 10.1007/s11033-025-10751-5↗
  2. SMAD4 depletion enhances NHEJ by regulating BRCA1 expression through ARIH1 in pancreatic cancer. Co-author DOI 10.1016/j.apsb.2025.03.035↗
  3. METTL3/IGF2BP3 mediates ORC6 via N6-methyladenosine modification to promote the progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gene.2025.149468↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyong Yang · 1 shared paper, 2025 · strength 0.30
  2. Feng Wang · 1 shared paper, 2025 · strength 0.26
  3. Yang Wang · 1 shared paper, 2025 · strength 0.26
  4. Yiran Song · 1 shared paper, 2025 · strength 0.26
  5. Zhi‐Nan Chen · 1 shared paper, 2025 · strength 0.23
  6. Zhiyong Yang · 1 shared paper, 2025 · strength 0.23
  7. Wenjing Song · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.